Clinician-reviewed CDS · Browser-local · No identifiers · Source-linkedRead more…
This tool is educational and informational. It does not replace clinical judgment. Verify trial populations, sICH definitions, BP target ranges, and post-treatment monitoring against the cited source before acting.
Not prospectively validated. No clinical tool replaces bedside assessment.
This tool qualifies as non-device clinical decision support under the January 2026 FDA CDS guidance (21st Century Cures Act §3060). It does not acquire or analyze patient data, it displays the basis for its recommendations, it enables independent clinician review, and it is intended for use by trained healthcare professionals.
This runs entirely in your browser; we store nothing. Even so, enter only clinical data (age, vitals, exam findings) -- not names, MRNs, or other identifiers.
Tarvinder Singh, MD -- Vascular Neurologist. March 2026.
Stroke
Hyperacute reperfusion decisions, post-treatment monitoring, hemorrhage management, TIA triage, and mechanism-specific secondary prevention.
Acute Ischemic Stroke
IVT and EVT eligibility by time window, imaging, and contraindication profile. Matches against AHA/ASA 2026 guidelines and trial populations.
Use when Acute stroke code with possible large vessel occlusion. Determines IVT and EVT eligibility in real time.
Open →
Post-IVT Care
First-24-hour monitoring after IV thrombolysis: BP targets, sICH recognition, imaging timing, and rescue protocols
Use when After IVT administration. Guides BP checks, sICH vigilance, and next-day planning.
Open →
Post-EVT Care
First-24-hour monitoring after thrombectomy: BP by reperfusion grade, groin-site care, and contrast nephropathy prevention
Use when After thrombectomy. Guides BP by reperfusion grade and post-procedural monitoring.
Open →
TIA Rapid Assessment
Risk stratification, DAPT timing by CHANCE/POINT/THALES evidence, and urgent workup priorities
Use when Transient neurologic deficit resolved on arrival. Stratifies risk and guides DAPT timing.
Open →
Secondary Prevention
Mechanism-specific antithrombotic selection, anticoagulation timing, and PFO/cryptogenic stroke pathway
Use when Stroke mechanism established. Selects antithrombotic strategy by etiology.
Open →
ICH Management
ICH score, BP targets, anticoagulant reversal, seizure management, and surgical decision cues
Use when Intracerebral hemorrhage confirmed on imaging. Guides severity scoring, reversal, and BP management.
Open →
Pediatric Stroke
Pediatric IVT and EVT review with age-specific dosing, etiology considerations, and safety cautions
Use when Pediatric acute ischemic stroke (age 2-17). Weight-based dosing with etiology-specific pathways.
Open →
Workflow
Start with acute ischemic stroke for IVT/EVT eligibility. Move to post-treatment care after reperfusion. Use ICH for hemorrhage management, TIA for rapid risk stratification, and secondary prevention for mechanism-specific antithrombotic selection.